Acute tacrolimus toxicity due to concomitant use of ritonavir (with nirmatrelvir as Paxlovid)

被引：0
|
作者：
Browne, Evan [1 ,4 ]
White, Cameron [2 ]
Darley, David [3 ]
Murnion, Bridin [4 ]
机构：
[1] St Vincents Hosp, Clin Pharmacol & Toxicol Adv Trainee, Sydney, Australia
[2] St Vincents Hosp, Resp Med Adv Trainee, Sydney, Australia
[3] St Vincents Hosp, Sydney, Australia
[4] UNSW Sydney, Fac Med & Hlth, Sch Clin Med, St Vincents Healthcare Clin Campus,Clin Pharmacol, Sydney, Australia
来源：
AUSTRALIAN PRESCRIBER | 2024年 / 47卷 / 06期
关键词：
COVID-19; drug interactions; nirmatrelvir; Paxlovid; ritonavir; tacrolimus;
D O I：
10.18773/austprescr.2024.052
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：192 / 193
页数：2
相关论文
共 50 条
  • [31] Nirmatrelvir+ritonavir/tacrolimus interactionDrug toxicity secondary to increased drug levels: case report
    Reactions Weekly, 2022, 1931 (1) : 465 - 465
  • [32] Risk of Acute Liver Injury Following the Nirmatrelvir/Ritonavir Use
    Ning, Jiliang
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [33] Risk of acute liver injury following the nirmatrelvir/ritonavir use
    Wong, Carlos King Ho
    Mak, Lung Yi
    Au, Ivan Chi Ho
    Cheng, Wing Yiu
    So, Ching Hei
    Lau, Kristy Tsz Kwan
    Lau, Eric Ho Yin
    Cowling, Benjamin J.
    Leung, Gabriel M.
    Yuen, Man Fung
    LIVER INTERNATIONAL, 2023, 43 (12) : 2657 - 2667
  • [34] Characterization of nirmatrelvir-ritonavir (Paxlovid®) calls managed by a regional poison center
    Lam, Angela
    Yemets, Masha
    Couch, Denise
    Leonard, James
    CLINICAL TOXICOLOGY, 2023, 61 : 109 - 109
  • [35] Everolimus/nirmatrelvir+ritonavir/tacrolimus interactionOff-label use and thrombotic microangiopathy following drugs toxicity: case report
    Reactions Weekly, 2023, 1970 (1) : 135 - 135
  • [36] Paxlovid (Nirmatrelvir and Ritonavir) Use in Pregnant and Lactating Woman: Current Evidence and Practice Guidelines-A Scoping Review
    Chourasia, Prabal
    Maringanti, Babu Sriram
    Edwards-Fligner, Morgan
    Gangu, Karthik
    Bobba, Aniesh
    Sheikh, Abu Baker
    Shekhar, Rahul
    VACCINES, 2023, 11 (01)
  • [37] Effects of nirmatrelvir/ritonavir (Paxlovid) on the nervous system: analysis on adverse events released by FDA
    Gao, Caixia
    Liu, Zhihui
    Zou, Zhen
    Mao, Lejiao
    Zhang, Jun
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [38] Tacrolimus Level Increase During Nirmatrelvir-Ritonavir Treatment
    Gong, Yinhua
    Li, Yue
    Xue, Ling
    Gao, Jie
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (04) : e458 - e461
  • [39] Nirmatrelvir+ritonavir/tacrolimus interactionVarious toxicities following drug interaction, drug toxicity and off-label use: case report
    Reactions Weekly, 2023, 1958 (1) : 412 - 412
  • [40] Nirmatrelvir+ritonavir/tacrolimus interactionAcute kidney injury and off label use: case report
    Reactions Weekly, 2023, 1963 (1) : 417 - 417
12345